Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Luminal water and electrolyte content refers to the volume and ionic composition of the fluid residing within the gastrointestinal tract. This physiological parameter is regulated by the complex interplay of epithelial ion channels, such as the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), and transporters like the Sodium-Hydrogen Exchanger 3 (NHE3) (StatPearls, 2023; Journal of Clinical Investigation, 2019). Maintaining an optimal balance is essential for effective nutrient absorption, lubrication of the mucosal surface, and the regulation of stool consistency and transit (American Journal of Gastroenterology, 2021). Dysregulation of luminal fluid leads to significant clinical pathologies; for instance, excessive secretion or reduced absorption results in diarrhea, while excessive absorption or reduced secretion leads to constipation (Nature Reviews Gastroenterology & Hepatology, 2017). While not a molecular target itself, it serves as a primary therapeutic endpoint for various drugs. Pharmacological agents like Linaclotide and Tenapanor modulate this content by targeting specific membrane proteins to alter ion flux, thereby correcting fluid imbalances in conditions such as Irritable Bowel Syndrome (Alimentary Pharmacology & Therapeutics, 2014).
Modulation of epithelial ion transport (e.g., via CFTR, ClC-2, or NHE3) to alter the osmotic gradient, thereby increasing or decreasing net fluid secretion into the gastrointestinal lumen (Nature Reviews Gastroenterology & Hepatology, 2017).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Luminal water and electrolyte content.